{
    "2020-11-12": [
        [
            {
                "time": "",
                "original_text": "医药关于疫苗行业跟踪点评：辉瑞BIOTECH中期数据乐观 关注疫苗和低温存储产业链机会",
                "features": {
                    "keywords": [
                        "疫苗",
                        "辉瑞",
                        "BIOTECH",
                        "中期数据",
                        "乐观",
                        "低温存储",
                        "产业链"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业重大事件快评：全球首个新冠疫苗中期分析显示保护力超90％",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠疫苗",
                        "中期分析",
                        "保护力",
                        "90%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业11月月报暨三季报总结：三季报医药整体表现良好 当前时点重点关注Q3业绩超预期的疫苗、CXO、医疗服务、零售药店等板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "疫苗",
                        "CXO",
                        "医疗服务",
                        "零售药店",
                        "Q3业绩",
                        "超预期"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗",
                        "CXO",
                        "医疗服务",
                        "零售药店"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业获融资客加仓，5只个股净买入额超亿元",
                "features": {
                    "keywords": [
                        "医药生物",
                        "融资客",
                        "加仓",
                        "净买入额",
                        "超亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "股权激励难抵市值缩水700亿 沃森生物遭遇机构与股东组团减持 连续下跌",
                "features": {
                    "keywords": [
                        "股权激励",
                        "市值缩水",
                        "沃森生物",
                        "机构减持",
                        "股东减持",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "沃森生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}